Ascelia Pharma AB
STO:ACE

Watchlist Manager
Ascelia Pharma AB Logo
Ascelia Pharma AB
STO:ACE
Watchlist
Price: 3 SEK 2.04%
Market Cap: 380.6m SEK

Intrinsic Value

The intrinsic value of one ACE stock under the Base Case scenario is 5.32 SEK. Compared to the current market price of 3 SEK, Ascelia Pharma AB is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACE Intrinsic Value
5.32 SEK
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ascelia Pharma AB

What is Valuation History?
Ask AI Assistant
What other research platforms think about ACE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ACE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ascelia Pharma AB.

Explain Valuation
Compare ACE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ACE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ascelia Pharma AB

Current Assets 78.2m
Cash & Short-Term Investments 72.3m
Receivables 3.1m
Other Current Assets 2.8m
Non-Current Assets 58.2m
PP&E 1.2m
Intangibles 57.1m
Other Non-Current Assets -1k
Current Liabilities 21.7m
Accounts Payable 7.2m
Accrued Liabilities 12.6m
Other Current Liabilities 1.9m
Non-Current Liabilities 284k
Long-Term Debt 285k
Other Non-Current Liabilities -1k
Efficiency

Free Cash Flow Analysis
Ascelia Pharma AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ascelia Pharma AB

Revenue
0 SEK
Operating Expenses
-80.5m SEK
Operating Income
-80.5m SEK
Other Expenses
-8.2m SEK
Net Income
-88.7m SEK
Fundamental Scores

ACE Profitability Score
Profitability Due Diligence

Ascelia Pharma AB's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
27/100
Profitability
Score

Ascelia Pharma AB's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ACE Solvency Score
Solvency Due Diligence

Ascelia Pharma AB's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
61/100
Solvency
Score

Ascelia Pharma AB's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACE Price Targets Summary
Ascelia Pharma AB

Wall Street analysts forecast ACE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACE is 8.16 SEK with a low forecast of 6.57 SEK and a high forecast of 9.98 SEK.

Lowest
Price Target
6.57 SEK
119% Upside
Average
Price Target
8.16 SEK
172% Upside
Highest
Price Target
9.98 SEK
233% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ascelia Pharma AB
does not pay dividends
Shareholder Yield

Current shareholder yield for ACE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ACE stock?

The intrinsic value of one ACE stock under the Base Case scenario is 5.32 SEK.

Is ACE stock undervalued or overvalued?

Compared to the current market price of 3 SEK, Ascelia Pharma AB is Undervalued by 44%.

Back to Top